Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
about
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsRole of occult hepatitis B virus infection in chronic hepatitis CCannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis CInvestigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.Vertical transmission of hepatitis B virus: challenges and solutionsInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionMK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Lack of association between interleukin 28B gene polymorphisms (rs8099917G/T, rs12979860 C/T) and susceptibility to chronic hepatitis C virus infection, Tehran, Iran.Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection.Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.Discontinued drugs in 2012 - 2013: hepatitis C virus infection.The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C.HBV/HCV co-infection is associated with a high level of HCV spontaneous clearance among drug users and blood donors in China.Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.Vedroprevir in the management of hepatitis C virus infection.HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
P2860
Q26782033-C2F3BFD1-3C23-439E-A30B-D4AC4C86B5D2Q26823538-76054DE2-9A81-4362-9D62-7D56B0ED543DQ28539814-E0FBE1A5-35B8-488E-A9BB-FE7325475BF2Q31051529-EDCAF1AE-0BE8-4C69-B045-FD21E5932558Q33735206-B4ADC605-BA0F-49A0-8D3C-BCB9AE3CD5F6Q33774099-67531824-D258-4717-B1A6-E6558350ADF2Q34263370-46759495-A78B-4303-8548-E33A8B5B7ECAQ34411907-DA2CFBFD-9D8A-4863-9D3F-FB15259F4A0CQ34420891-DF8530D5-BD69-4CA8-A2B9-F58669C2E87DQ34424151-442EEFAE-D272-41DB-9569-C2A986118BA2Q37643650-120EEAEE-EAA5-4378-A087-11A9A22FCFF5Q38212793-44CC6308-E72B-4B34-8225-280484EF67D4Q38233860-F44F73E7-86D7-413A-9066-F6452A975399Q38235178-30B45D3D-6517-4994-B672-8DF24133C5FDQ38995225-0A0AAB27-3A89-4628-9CFE-67D92625D59AQ39100351-3FAA2E8D-82D1-4F34-89F5-04F2C9941F88Q40326326-2256E9E7-F89C-48B9-9367-1B8460AAD0BFQ40413383-E09F5E0D-1DAB-4A66-9887-7308D087389AQ41221366-30B557CC-A507-44FC-AC17-4D0D3DF6DCB7Q45325957-D5A87E77-616A-44C8-A37D-19980352EA5BQ57066911-576A859C-AD30-41EE-B463-D38F1A7B33E7
P2860
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@en
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@nl
type
label
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@en
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@nl
prefLabel
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@en
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@nl
P2093
P2860
P50
P1476
Role of interleukin 28-B in th ...... hronic HBV/HCV dual infection.
@en
P2093
L E Adinolfi
P2860
P2888
P304
P356
10.1007/S10096-013-1985-7
P50
P577
2013-10-01T00:00:00Z
P5875
P6179
1005364695